Liver cirrhosis is known to affect the soluble inflammatory milieu during chronic HCV infection, thereby increasing plasma levels of adhesion molecules such as VCAM-1 and ICAM-1, as well as decreasing levels of the cytokines IL-17 and the growth factors FGF-β and PDGF-BB in plasma41. This evidence concerns the gene FGF2 and cirrhosis of liver.